Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene
- PMID: 18997677
- DOI: 10.1038/oby.2008.422
Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene
Abstract
Because information on weight changes after lifestyle intervention in children with mutations in the melanocortin 4 receptor (MC4R) gene is scarce, we compared weight changes after lifestyle intervention between children with and without MC4R variations. A group of 514 overweight children (aged 5-16 years), who presented to participate in a 1-year lifestyle intervention based on exercise, behavior, and nutrition therapy were screened for MC4R mutations. For comparison, children with MC4R mutations leading to reduced receptor function (group A) were each of them randomly matched with five children of same age and gender without MC4R mutations (group B). Changes of weight status were analyzed as change of BMI standard deviation scores (BMI-SDSs). Furthermore, 16 children (3.1%) harbored MC4R mutations leading to reduced receptor function, and 17 (3.3%) children carried variations not leading to reduced receptor function. Children with and without MC4R mutations reduced their overweight at the end of intervention to a similar degree (P = 0.318 between groups based on an intention-to-treat analysis). The maintenance of weight loss after intervention among children with MC4R mutations leading to reduced receptor function failed in contrast to children without such mutations (P < 0.001 adjusted for BMI-SDS at baseline, age, and gender in an intention-to-treat analysis). In conclusion, children with MC4R mutations leading to reduced receptor function were able to lose weight in a lifestyle intervention but had much greater difficulties to maintain this weight loss supporting the impact of these mutations on weight status.
Similar articles
-
A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population.Clin Endocrinol (Oxf). 2007 May;66(5):652-8. doi: 10.1111/j.1365-2265.2007.02788.x. Clin Endocrinol (Oxf). 2007. PMID: 17492953
-
Leptin concentrations are a predictor of overweight reduction in a lifestyle intervention.Int J Pediatr Obes. 2009;4(4):215-23. doi: 10.3109/17477160902952464. Int J Pediatr Obes. 2009. PMID: 19922035 Clinical Trial.
-
A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.Exp Clin Endocrinol Diabetes. 2007 Jan;115(1):7-12. doi: 10.1055/s-2007-949150. Exp Clin Endocrinol Diabetes. 2007. PMID: 17286227 Clinical Trial.
-
Obesity-associated mutations in the human melanocortin-4 receptor gene.Peptides. 2006 Feb;27(2):395-403. doi: 10.1016/j.peptides.2005.03.064. Epub 2005 Nov 4. Peptides. 2006. PMID: 16274851 Review.
-
[Obesity caused by melanocortin-4 receptor mutations].Ned Tijdschr Geneeskd. 2012;156(32):A4548. Ned Tijdschr Geneeskd. 2012. PMID: 22871247 Review. Dutch.
Cited by
-
Interactions between obesity-related copy number variants and dietary behaviors in childhood obesity.Nutrients. 2015 Apr 22;7(4):3054-66. doi: 10.3390/nu7043054. Nutrients. 2015. PMID: 25912042 Free PMC article.
-
One-on-one lifestyle coaching for managing adolescent obesity: Findings from a pilot, randomized controlled trial in a real-world, clinical setting.Paediatr Child Health. 2011 Jun;16(6):345-50. doi: 10.1093/pch/16.6.345. Paediatr Child Health. 2011. PMID: 22654546 Free PMC article.
-
Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R).Physiol Res. 2020 Sep 30;69(Suppl 2):S245-S254. doi: 10.33549/physiolres.934512. Physiol Res. 2020. PMID: 33094623 Free PMC article. Review.
-
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.Mol Metab. 2017 Oct;6(10):1321-1329. doi: 10.1016/j.molmet.2017.06.015. Epub 2017 Jul 8. Mol Metab. 2017. PMID: 29031731 Free PMC article. Clinical Trial.
-
Case report: Nerve fiber regeneration in children with melanocortin 4 receptor gene mutation related obesity treated with semaglutide.Front Endocrinol (Lausanne). 2024 Jun 21;15:1385463. doi: 10.3389/fendo.2024.1385463. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38974580 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical